Evidence map›Paper›PMID 41778748›Full record

GuidelineJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2026

Evidence- and consensus-based guideline on lichen sclerosus.

Gudula Kirtschig, Linn Woelber, Andreas Günthert, Karl Becker, Alexandra Ciresa-König, Bettina Fischer, Susanne Fricke-Otto, Claudia Günther, Christine Hirchenhain, Narayani Helga Köllmann and 16 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Gudula KirtschigMedbase Health Centre Frauenfeld, Frauenfeld, Switzerland.
Linn WoelberDysplasia Center, Jerusalem Hospital, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Andreas Günthertgyn-zentrum Luzern Cham Kriens, Lucerne, Switzerland.
Karl BeckerOffice for Pediatric Surgery Bonn, Bonn, Germany.
Alexandra Ciresa-KönigUniversity Hospital for Gynecology and Obstetrics, Medical University Innsbruck, Innsbruck, Austria.
Bettina FischerSwiss Lichen Sclerosus Association, Dottikon, Switzerland.
Susanne Fricke-OttoDepartment of Pediatric Endocrinology and Diabetes, Pediatric Emergency Treatment, HELIOS Hospital Krefeld, Krefeld, Germany.
Claudia GüntherDepartment of Dermatology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0002-4330-1861
Christine HirchenhainDepartment of Gynecology and Obstetrics, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
Narayani Helga KöllmannSwiss Lichen Sclerosus Association, Dottikon, Switzerland.
Alexander KreuterDepartment of Dermatology, Venereology and Allergology, Helios St. Elisabeth Hospital Oberhausen, Oberhausen, Germany.ORCID https://orcid.org/0000-0003-2275-499X
Bartosz MalisiewiczMain Medic. All, Office, Frankfurt am Main, Germany.
Felix NeisDepartment of Gynecology and Obstetrics, University Hospital Tübingen, Tübingen, Germany.
Dan Mon O'DeyLuisenhospital Aachen/Department of Plastic, Reconstructive, and Aesthetic Surgery, Hand Surgery, Center for Reconstructive Surgery of Female Genitalia, Aachen, Germany.
Hagen OttMUC-iSPZ Hauner, LMU Center for Children With Medical and Developmental Complexity, Ludwig Maximilian University Munich, Munich, Germany.
Martin PrommBarmherzige Brüder Regensburg, Department of Pediatric Urology, Regensburg, Germany.
Regina RennerDermatology Office Esslingen, Esslingen, Germany.ORCID https://orcid.org/0000-0002-0166-4381
Anne-Rose SchardtJoint Office Ihre Frauenärztinnen im Taunusstein, Taunusstein, Germany.
Ines SchweizerOffice for Sexual and Psychotherapy, Lucerne, Switzerland.
Raimund SteinCenter for Pediatric, Adolescent and Reconstructive Urology, University Medical Center Mannheim, Mannheim, Germany.
Jan Ter-NeddenDermatopathological and Pathological Laboratory Center Hamburg, Hamburg, Germany.
Gerda TrutnovskyDepartment of Gynecology and Obstetrics, Medical University of Graz, Graz, Austria.
Agnes WandAlice Salomon University Berlin, Berlin, Germany.
Gerhard WeyandtDepartment of Dermatology, Allergology and Venereology, Bayreuth Hospital, Bayreuth, Germany.
Ricardo N WernerDivision of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-3209-1392
Maria KinbergerDivision of Evidence-Based Medicine (dEBM), Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The German-language, consensus- and evidence-based S3 guideline on lichen sclerosus (LS) was developed based on the European "EuroGuiDerm Guideline on lichen sclerosus" under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG). Particular emphasis was placed on adapting the recommendations to the healthcare conditions in German-speaking countries. The interdisciplinary guideline development group consisted of 24 experts from 16 medical societies and actively included patient representatives in the development process. The guideline provides comprehensive recommendations on diagnosis, patient management, follow-up care, and patient education, as well as the treatment of both genital and extragenital LS in women, men, girls, and boys. Regardless of age or sex, ultrapotent or potent topical glucocorticosteroids in combination with emollients remain the standard therapy for genital LS. In male patients with LS-associated phimosis who do not respond sufficiently to standard therapy, circumcision with complete removal of the foreskin is indicated. For extragenital LS, phototherapy with UV light is recommended as an adjunct to topical treatment. Topical calcineurin inhibitors are second-line therapy.

Indexed as

Lichen Sclerosus et AtrophicusAdministration, TopicalCalcineurin InhibitorsCircumcision, MaleEvidence-Based MedicineFemaleGermanyGlucocorticoidsHumansMaleCalcineurin InhibitorsGlucocorticoidsEvidence‐based guidelineguidelinelichen sclerosus

Identifiers

PMID41778748
PMCPMC13059072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.